Centre for Immunobiology: Recent submissions
Now showing items 101-120 of 1121
-
297-OR: Systematic Review of Immune Interventions Trials in Recent Onset Type 1 and Effect on HbA1c
(American Diabetes Association, 2023-06-20) -
Assessment of Platelet Function by High-Throughput Screening Light Transmission Aggregometry: Optimul Assay.
(2023)Platelet function testing is critical in the diagnosis of bleeding disorders and allows monitoring of antiplatelet therapy. The gold standard assay, light transmission aggregometry (LTA), was developed 60 years ago and ... -
Oral Presentation No. 093 Assessing different noncoding RNAs as markers of platelet reactivity
(Oxford University Press (OUP), 2022-10-21) -
Vitamin D supplementation to prevent tuberculosis infection in South African schoolchildren: multicenter phase 3 double-blind randomized placebo-controlled trial (ViDiKids).
(2023-09)OBJECTIVES: To determine whether weekly oral supplementation with 10,000 IU vitamin D3 for 3 years reduces the risk of sensitization to M. tuberculosis in South African schoolchildren aged 6-11 years with negative ... -
Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials.
(2023-05)BACKGROUND: Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) is a single-tablet regimen recommended for HIV-1 treatment. The safety and efficacy of B/F/TAF as initial therapy was established in two Phase 3 studies: ...